A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma.

ABSTRACT:

Background

Real-world data on treatment and outcomes in patients with synchronous metastatic disease compared with patients with metachronous metastatic disease in esophagogastric cancer have not been published before. The aim of our study was to explore treatment, overall survival (OS), and time to treatment fialure (TTF) in patients with synchronous and metachronous metastatic esophagogastric adenocarcinoma.

Methods

Patients with synchronous metastatic disease (2015-2017) and patients with metachronous metastatic disease initially treated with curative intent for nonmetastatic disease (2015-2016) were selected from the Netherlands Cancer Registry. OS and TTF were assessed from metastatic diagnosis for patients with synchronous, early metachronous (⩽6 months) or late metach

SUBMITTER: Pape M 

PROVIDER: S-EPMC8958715 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature